Re-Examination of 2017 ELN Risk Classification By a Cohort of 739 De Novo aml Patients in Taiwan: Co-Occurring Poor-Risk Mutations May Further Predict Outcome in FLT3-ITD Patients
Journal
Blood
Journal Volume
132
Journal Issue
Supplement 1
Start Page
3977
End Page
3977
ISSN
0006-4971
1528-0020
Date Issued
2018-11-29
Author(s)
Sheng-Chuan Huang
Yuan-Yeh Kuo
Mei-Hsuan Tseng
Chien-Ting Lin
Abstract
Disclosures
Ko: Roche: Research Funding; GNT Biotech & Medicals Crop.: Research Funding; Abbevie: Research Funding; Mumdipharma Taiwan: Consultancy.
Ko: Roche: Research Funding; GNT Biotech & Medicals Crop.: Research Funding; Abbevie: Research Funding; Mumdipharma Taiwan: Consultancy.
Publisher
American Society of Hematology
Type
journal article